Publication protocol
Breastoid purification: Human breast tissue from reduction mammoplasty or from the normal margin that was removed during breast cancer surgery was collected as waste tissue with institutional review board approval. A list of the age and race for each of the patient samples used in this study is provided (Supplemental Table 1). The tissue was weighed and minced with scissors into 1-mm3 portions. A portion was taken for fixing in 10% formalin (Protocol) for 2 d and then placed in 70% ethanol. The fixed samples were paraffin-embedded and 5-μm sections were prepared by the University of Virginia Research Histology Core. Tissue was sometimes cryopreserved by adding an equivalent weight of 90% breastoid base medium (BBM) (DMEM/F12 with 15 mM HEPES at pH 7.4 [Invitrogen] [DMEM/F12], 100 μM ethanolamine [Sigma], 1 μg/mL hydrocortisone [Sigma], 10 μg/mL insulin–5.5 μg/mL transferrin–6.7 ng/mL selenium [Invitrogen], 100 U/mL penicillin–100 μg/mL streptomycin [Invitrogen], 2.5 μg/mL Amphotericin B [Sigma], 50 μg/mL gentamicin [Invitrogen]), 5% fetal bovine serum (FBS) (Atlanta Biologicals), and 5% dimethyl sulfoxide. The tissue was thawed at 37°C and placed in prewarmed DMEM/F12 before proceeding. Approximately 15 g of fresh or thawed tissue was digested for 18–21 h at 37°C in a 5% CO2 incubator with sterile 25 mL of Collagenase A medium (DMEM/F12, 1 mg/mL Collagenase A [Roche], 1 μg/mL insulin [Sigma], 600 U/μL Nystatin (Sigma), 100 U/mL penicillin–100 μg/mL streptomycin [Invitrogen]). If the sample was very fibrous, additional Collagenase A medium was added at 16–17 h. The digested material was centrifuged at 180g for 5 min and the solubilized material was decanted from the pellet containing the breastoids. The pellet was washed in 5 mL of prewarmed DMEM/F12 medium. The pellet was resuspended in 5 mL of prewarmed DMEM/F12 with DNase I (1000 U/mL) (Sigma) for 3–5 min at 37°C in a 5% CO2 incubator. FBS (0.5 mL) was added and the suspension was centrifuged at 180g for 10 min. The pellet was resuspended in 9 mL of phosphate-buffered saline (PBS) with 5% FBS and centrifuged at 350g for 15 sec. This wash step was repeated six times. Any fibrous tissue was removed manually. The pellet was resuspended in 9 mL of DMEM/F12 and centrifuged at 350g for 15 sec. The pellet was resuspended in 1 mL of BBM. An aliquot was removed and the number of breastoids was counted.
For breastoid and mouse organoid plating, a volume of 60 μL of a 60% Matrigel (BD Biosciences) solution in BBM was added into each well of an eight-well LabTek chamber (Thermo Scientific) and allowed to solidify for 15 min in a 37°C 5% CO2incubator. In a separate tube, 30–40 medium-sized breastoids or mouse organoids per well were added and the volume was brought up to 40 μL using a 50% Matrigel solution in BBM. This mixture was added to the solidified Matigel and allowed to solidify for 15 min in a 37°C 5% CO2 incubator. BBM (350 μL) supplemented with growth factors was then added. EGF (Calbiochem), FGF7 (R&D Systems), AREG (R&D Systems), NRG1-β1 (R&D Systems), and TGFα (Sigma) were used at 5 nM, and FGF2 (R&D Systems) was used at 1 nM unless stated otherwise. The medium was replaced every 2–3 d. U0126 (20 μM) (Sigma) and SL0101 (100 μM) were added with fresh medium every 48 h.
Full paper
Login or
join for free to view the full paper.
Videos
Check out videos that might be relevant for performing 3D Cell Culture Media Human primary breast ephitelial cells-organoids using Gibco DMEM/F-12, HEPES from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.